A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study)

OBJECTIVE: We aimed to test our hypothesis that traditional Japanese (Kampo) medicine, hochuekkito (Hochu-ekki-to: HET) has a preventive effect for the symptoms on COVID-19. TRIAL DESIGN: The study is designed as a multi-center, interventional, parallel-group, randomized (1:1 ratio), investigator sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Namiki, Takao, Takayama, Shin, Arita, Ryutaro, Ishii, Tadashi, Kainuma, Mosaburo, Makino, Toshiaki, Mimura, Masaru, Yoshino, Tetsuhiro, Nogami, Tatsuya, Arai, Makoto, Sato, Juichi, Tanaka, Koichiro, Nakae, Hajime, Igari, Hidetoshi, Ozawa, Yoshihito, Shiko, Yuki, Kawasaki, Yohei, Nezu, Masahiko, Ito, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787232/
https://www.ncbi.nlm.nih.gov/pubmed/33407828
http://dx.doi.org/10.1186/s13063-020-04939-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787232/
https://www.ncbi.nlm.nih.gov/pubmed/33407828
http://dx.doi.org/10.1186/s13063-020-04939-2

Ejemplares similares